India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:532810 has a market cap or net worth of INR 1.34 trillion.
| Market Cap | 1.34T |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
| Current Share Class | 3.30B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.42B |
Valuation Ratios
The trailing PE ratio is 5.49 and the forward PE ratio is 6.73.
| PE Ratio | 5.49 |
| Forward PE | 6.73 |
| PS Ratio | 2.81 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 6.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 880.67M |
| Profits Per Employee | 450.26M |
| Employee Count | 540 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532810 has paid 86.24 billion in taxes.
| Income Tax | 86.24B |
| Effective Tax Rate | 21.07% |
Stock Price Statistics
The stock price has decreased by -17.81% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -17.81% |
| 50-Day Moving Average | 415.24 |
| 200-Day Moving Average | 425.63 |
| Relative Strength Index (RSI) | 41.87 |
| Average Volume (20 Days) | 236,425 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532810 had revenue of INR 475.56 billion and earned 243.14 billion in profits. Earnings per share was 73.68.
| Revenue | 475.56B |
| Gross Profit | 472.72B |
| Operating Income | 418.04B |
| Pretax Income | 409.37B |
| Net Income | 243.14B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 73.68 |
Balance Sheet
The company has 256.88 billion in cash and 9.88 trillion in debt, giving a net cash position of -9,624.07 billion.
| Cash & Cash Equivalents | 256.88B |
| Total Debt | 9.88T |
| Net Cash | -9,624.07B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.55T |
| Book Value Per Share | 356.77 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 99.40%, with operating and profit margins of 87.90% and 51.13%.
| Gross Margin | 99.40% |
| Operating Margin | 87.90% |
| Pretax Margin | 86.08% |
| Profit Margin | 51.13% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 15.80, which amounts to a dividend yield of 3.87%.
| Dividend Per Share | 15.80 |
| Dividend Yield | 3.87% |
| Dividend Growth (YoY) | 17.04% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.87% |
| Earnings Yield | 18.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 21, 2023. It was a forward split with a ratio of 1.25.
| Last Split Date | Sep 21, 2023 |
| Split Type | Forward |
| Split Ratio | 1.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |